Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A randomized trial of the electronic Lung Cancer Symptom Scale for quality-of-life assessment in patients with advanced non-small-cell lung cancer.
Current oncology (Toronto, Ont.)·2020
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
A phase III study evaluating the safety and efficacy of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting over repeated cycles of chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Efficacy and safety of NEPA, an oral combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy: a randomized dose-ranging pivotal study.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2006
A comparison of visual analogue and numerical rating scale formats for the Lung Cancer Symptom Scale (LCSS): does format affect patient ratings of symptoms and quality of life?
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2005
Therapeutic Potential of Bone Marrow-Derived Mesenchymal Stem Cells in A Letrozole-Induced Rat Model of Polycystic Ovary Syndrome.
International journal of fertility & sterility·2026
CCR1 Antagonism by BX471 Attenuates Neuroinflammation and Apoptosis: Preliminary Findings From an In Vitro Model of Neuronal Injury.
Pharmacology research & perspectives·2026
[Drug sensitivity analysis of monotherapy and combination therapy with Chinese and Western drugs in lung cancer organoid models].
Zhonghua zhong liu za zhi [Chinese journal of oncology]·2026
Central Blockade of Cannabinoid CB1 and CB2 Receptors Increases Force Generation in Reserpine-Treated Mice, but Only CB1 Blockade Extends the Duration of Effort.
ACS pharmacology & translational science·2026